ArticleAnnals of medicine2022

Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy.

Min Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.